Page last updated: 2024-11-01

o(6)-benzylguanine and Medulloblastoma

o(6)-benzylguanine has been researched along with Medulloblastoma in 5 studies

O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research Excerpts

ExcerptRelevanceReference
"This study was designed to determine whether resistance to the activity of nitrosourea (the drug BCNU) in BCNU-resistant human medulloblastoma (D341 Med) and human glioblastoma multiforme (D-456 MG) can be reversed by the methylating agent streptozocin and the O6-substituted guanines O6-methylguanine and O6-benzylguanine."3.68Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. ( Bigner, DD; Dolan, ME; Felker, GM; Friedman, HS; Moschel, RC; Pegg, AE; Rich, J; Schold, SC, 1992)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shankar, S1
Zalutsky, MR1
Friedman, H1
Vaidyanathan, G1
Felker, GM2
Friedman, HS2
Dolan, ME3
Moschel, RC2
Schold, C1
Rhines, LD1
Sampath, P1
Tyler, BM1
Brem, H1
Weingart, J1
Pegg, AE1
Rich, J1
Bigner, DD1
Schold, SC1
Silber, JR1
Bobola, MS1
Ewers, TG1
Muramoto, M1
Berger, MS1

Other Studies

5 other studies available for o(6)-benzylguanine and Medulloblastoma

ArticleYear
Molecular imaging of alkylguanine-DNA alkyltransferase: further evaluation of radioiodinated derivatives of O6-benzylguanine.
    Nuclear medicine and biology, 2006, Volume: 33, Issue:3

    Topics: Animals; Benzoflavones; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Guanine; Humans; Iod

2006
Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Drug Synergism

1993
O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
    Cancer research, 2000, Nov-15, Volume: 60, Issue:22

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Ne

2000
Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.
    Journal of the National Cancer Institute, 1992, Dec-16, Volume: 84, Issue:24

    Topics: Animals; Carmustine; Drug Resistance; Female; Glioblastoma; Guanine; Humans; Male; Medulloblastoma;

1992
O6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines.
    Oncology research, 1992, Volume: 4, Issue:6

    Topics: Carmustine; Cell Survival; Cerebellar Neoplasms; Drug Resistance; Guanine; Humans; Medulloblastoma;

1992